BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19551899)

  • 1. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis.
    Dayer Schneider J; Seibold I; Saxer-Sekulic N; Paredes BE; Saurer L; Mueller C
    Eur J Immunol; 2009 Jul; 39(7):1743-53. PubMed ID: 19551899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
    Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
    Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
    Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C theta plays a fundamental role in different types of chronic colitis.
    Nagahama K; Ogawa A; Shirane K; Shimomura Y; Sugimoto K; Mizoguchi A
    Gastroenterology; 2008 Feb; 134(2):459-69. PubMed ID: 18155708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous generation of colitogenic CD4(+) T cells in persistent colitis.
    Tomita T; Kanai T; Fujii T; Nemoto Y; Okamoto R; Tsuchiya K; Totsuka T; Sakamoto N; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1264-74. PubMed ID: 18412157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo.
    Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF
    Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.
    Punit S; Dubé PE; Liu CY; Girish N; Washington MK; Polk DB
    Gastroenterology; 2015 Oct; 149(4):993-1005.e2. PubMed ID: 26072395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis.
    Nemoto Y; Kanai T; Kameyama K; Shinohara T; Sakamoto N; Totsuka T; Okamoto R; Tsuchiya K; Nakamura T; Sudo T; Matsumoto S; Watanabe M
    J Immunol; 2009 Oct; 183(8):5059-68. PubMed ID: 19786550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated IL-7 receptor α expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis.
    Shinohara T; Nemoto Y; Kanai T; Kameyama K; Okamoto R; Tsuchiya K; Nakamura T; Totsuka T; Ikuta K; Watanabe M
    J Immunol; 2011 Feb; 186(4):2623-32. PubMed ID: 21217010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
    Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
    Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner.
    Noguchi D; Wakita D; Tajima M; Ashino S; Iwakura Y; Zhang Y; Chamoto K; Kitamura H; Nishimura T
    Int Immunol; 2007 Dec; 19(12):1431-40. PubMed ID: 17981790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion.
    Liu Z; Jiu J; Liu S; Fa X; Li F; Du Y
    J Autoimmun; 2007; 29(2-3):187-94. PubMed ID: 17804196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
    Liu Z; Geboes K; Heremans H; Overbergh L; Mathieu C; Rutgeerts P; Ceuppens JL
    Eur J Immunol; 2001 May; 31(5):1550-60. PubMed ID: 11465113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
    Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
    Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TNF-alpha but not transmembrane TNF-alpha sensitizes T cells for enhanced activation-induced cell death.
    Müller S; Rihs S; Schneider JM; Paredes BE; Seibold I; Brunner T; Mueller C
    Eur J Immunol; 2009 Nov; 39(11):3171-80. PubMed ID: 19681056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.